✦ LIBER ✦

O833 HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Correlation between serum and mucosal anti-HPV-16 and anti-HPV-18 antibody levels

✍ Scribed by Schwarz, T.; Kocken, M.; Petäjä, T.; Einstein, M.; Hardt, K.

Book ID: 122383727
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 107
Category: Article
ISSN: 0020-7292
DOI: 10.1016/S0020-7292(09)61206-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term persistence of anti-HPV-16 and

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses

✍ Marie-Pierre David; Koen Van Herck; Karin Hardt; Fabian Tibaldi; Gary Dubin; Dom 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 713 KB

Clinicopathologic characteristics of hum

Clinicopathologic characteristics of human papillomavirus (HPV) infection and serum anti-HPV 16/18 antibodies in cervical neoplasia

✍ D. Chay; H. Cho; J. Kim; S. Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Immunogenicity and tolerability of an HP

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years

✍ Tino F. Schwarz; Marek Spaczynski; Achim Schneider; Jacek Wysocki; Andrzej Galaj 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Modeling the impact of the difference in

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

✍ Michele Kohli, Donna Lawrence, Jennifer Haig, Andrea Anonychuk, Nadia Demarteau 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 391 KB

A review of cross-protection against onc

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

✍ David Jenkins 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Long-term persistence of systemic and mu

Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women

✍ Tiina Petäjä; Court Pedersen; Airi Poder; Gitte Strauss; Gregory Catteau; Floren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 610 KB

## Abstract Vaccination against oncogenic human papillomavirus (HPV) types is one key intervention for cervical cancer prevention. This follow‐up study assessed the persistence of the systemic and mucosal immune responses together with the safety profile of the HPV‐16/18 AS04‐adjuvanted vaccine adm